ALNY
Alnylam Pharmaceuticals Inc

4,409
Mkt Cap
$47.46B
Volume
1.53M
52W High
$495.55
52W Low
$205.87
PE Ratio
1,494.47
ALNY Fundamentals
Price
$359.00
Prev Close
$359.26
Open
$362.29
50D MA
$419.86
Beta
0.89
Avg. Volume
1.63M
EPS (Annual)
-$2.18
P/B
202.44
Rev/Employee
$1.01M
Loading...
Loading...
News
all
press releases
Donoghue Forlines LLC Takes $2.11 Million Position in Alnylam Pharmaceuticals, Inc. $ALNY
Donoghue Forlines LLC purchased a new position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Sees Significant Growth in Short Interest
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Get Free Report) was the recipient of a large growth in short interest during the month of December. As of December 31st, there was short interest...
MarketBeat·2d ago
News Placeholder
Wolverine Asset Management LLC Makes New Investment in Alnylam Pharmaceuticals, Inc. $ALNY
Wolverine Asset Management LLC purchased a new position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) in the 3rd quarter, according to its most recent filing with the Securities and...
MarketBeat·3d ago
News Placeholder
Campbell & CO Investment Adviser LLC Makes New Investment in Alnylam Pharmaceuticals, Inc. $ALNY
Campbell & CO Investment Adviser LLC bought a new stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) during the third quarter, according to the company in its most recent...
MarketBeat·4d ago
News Placeholder
A Look Into Alnylam Pharmaceuticals Inc's Price Over Earnings
read more...
Benzinga·4d ago
News Placeholder
EVP Of Alnylam Pharmaceuticals Sold $547K In Stock
read more...
Benzinga·5d ago
News Placeholder
Insider Selling: Jeffrey V Poulton Unloads $1.01M Of Alnylam Pharmaceuticals Stock
read more...
Benzinga·5d ago
News Placeholder
Alnylam Pharmaceuticals Chief Executive Officer Sold $3.48M In Company Stock
read more...
Benzinga·5d ago
News Placeholder
Alnylam Pharmaceuticals (NASDAQ:ALNY) EVP Sells $848,055.70 in Stock
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Get Free Report) EVP Kevin Joseph Fitzgerald sold 2,290 shares of the business's stock in a transaction that occurred on Tuesday, January 13th. The stock...
MarketBeat·5d ago
News Placeholder
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Average Recommendation of "Moderate Buy" from Analysts
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the twenty-seven ratings firms that are currently covering the firm...
MarketBeat·5d ago
<
1
2
...
>

Latest ALNY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.